Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Farxiga approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes
-
First quarter 2021 results
-
Selumetinib recommended for approval in the EU by CHMP as the first medicine for paediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
-
Tagrisso recommended for approval in the EU by CHMP for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
-
Nirsevimab MELODY Phase III trial met primary endpoint of reducing RSV lower respiratory tract infections in healthy infants
-
AstraZeneca receives US clearance of proposed acquisition of Alexion
-
Tagrisso approved in China for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
-
Update on the DARE-19 Phase III trial for Farxiga in COVID-19
-
AstraZeneca accelerates early oncology pipeline across key strategic scientific platforms at AACR
-
AZD1222 US Phase III primary analysis confirms safety and efficacy
Latest articles and press releases
All of our latest press releases and articles are available to explore
